US2016250408A1PendingUtilityA1

Nasal delivery method

Assignee: OPTINOSE ASPriority: Mar 3, 1999Filed: Dec 22, 2015Published: Sep 1, 2016
Est. expiryMar 3, 2019(expired)· nominal 20-yr term from priority
A61M 16/1065A61M 15/0065A61M 15/002A61M 3/0279A61M 15/0098A61M 16/1055A61M 2210/0618A61M 15/0028A61M 2202/064A61M 15/0021A61M 15/0091A61M 2206/14A61M 2210/0625A61M 16/0866A61M 2206/10A61M 15/009A61M 15/08A61M 15/0045A61M 2202/0468A61M 2205/43A61M 2205/59A61M 15/0018A61M 3/0233A61M 3/0202
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A delivery device ( 20, 22 ) for and a method of delivering a substance to the nasal airway ( 1 ) of a subject, in particular the posterior region of the nasal airway, the delivery device comprising: a closure unit for causing the closure of the oropharyngeal velum of the subject; and a delivery unit for delivering a gas flow entraining a substance to one of the nostrils of the subject at such a driving pressure as to flow around the posterior margin of the nasal septum and out of the other nostril of the subject, wherein the delivery unit comprises a nosepiece ( 30, 40, 58, 82, 102, 132 ) which includes an outlet through which the gas flow is in use delivered to the one nostril and a sealing member for sealing the one nostril to the outlet such as in use to prevent the escape of the gas flow through the one nostril.

Claims

exact text as granted — not AI-modified
1 - 34 . (canceled) 
     
     
         35 . A method of irrigating the nasal airway of a subject, comprising:
 sealing a first nostril of a subject to an outlet of a delivery unit;   closing the oropharyngeal velum of the subject; and   delivering an irrigating agent through the outlet of the delivery unit at such a driving pressure as to flow around the posterior margin of the nasal septum and out of the other, second nostril of the subject.   
     
     
         36 . The method of  claim 35 , further comprising:
 sealing the second nostril of the subject to the outlet of the delivery unit;   closing the oropharyngeal velum of the subject; and   delivering an irrigating agent through the outlet of the delivery unit at such a driving pressure as to flow around the posterior margin of the nasal septum and out of the first nostril of the subject.   
     
     
         37 . The method of  claim 35 , wherein the velum closure is provided by exhalation by the subject. 
     
     
         38 . The method of  claim 35 , wherein the irrigating agent is delivered in an exhalation flow. 
     
     
         39 . The method of  claim 35 , wherein the irrigating agent is delivered by actuation of a supply unit. 
     
     
         40 . The method of  claim 39 , wherein the supply unit is actuated by the exhalation flow of the subject. 
     
     
         41 . The method of  claim 35 , further comprising:
 providing a flow resistance to the nasal airway of the subject so as to maintain a dynamic positive pressure in the nasal airway of the subject.   
     
     
         42 . The method of  claim 41 , wherein the dynamic positive pressure is of sufficient magnitude as to force open at least one of the auditory tubes or the sinus tubes. 
     
     
         43 . The method of  claim 41 , wherein the dynamic positive pressure is at least 5 cm H 2 O. 
     
     
         44 . The method of  claim 41 , wherein the dynamic positive pressure is at least 50 cm H 2 O. 
     
     
         45 . The method of  claim 41 , further comprising:
 providing at least one of a visual or an audible signal when a predetermined dynamic positive pressure is achieved in the nasal airway of the subject.   
     
     
         46 . The method of  claim 35 , wherein the irrigating agent comprises a liquid. 
     
     
         47 . The method of  claim 46 , wherein the irrigating agent comprises saline. 
     
     
         48 . The method of  claim 46 , wherein the irrigating agent contains oils or herbs. 
     
     
         49 . The method of  claim 35 , wherein the irrigating agent is delivered in combination with a cleansing agent. 
     
     
         50 . The method of  claim 35 , in the treatment of nasal inflammation. 
     
     
         51 . The method of  claim 35 , in the treatment of rhinitis. 
     
     
         52 . The method of  claim 35 , in the treatment of nasal polyps. 
     
     
         53 . The method of claim  1 , in the treatment of hypertrophic adenoids. 
     
     
         54 . The method of  claim 35 , in the treatment of secretory otitis media. 
     
     
         55 . The method of  claim 35 , in the treatment of reduced olfaction.

Join the waitlist — get patent alerts

Track US2016250408A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.